Comparing human iPSC-cardiomyocytes versus HEK293T cells unveils disease-causing effects of Brugada mutation A735V of NaV1.5 sodium channels-Reference-Cited by-同舟云学术

Comparing human iPSC-cardiomyocytes versus HEK293T cells unveils disease-causing effects of Brugada mutation A735V of NaV1.5 sodium channels

Published:2019-08-01 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

de la Roche Jeanne^ORCID,Angsutararux Paweorn,Kempf Henning,Janan Montira,Bolesani Emiliano,Thiemann Stefan,Wojciechowski Daniel,Coffee Michelle,Franke Annika,Schwanke Kristin,Leffler Andreas,Luanpitpong Sudjit^ORCID,Issaragrisil Surapol,Fischer Martin,Zweigerdt Robert^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-47632-4.pdf

Reference38 articles.

1. Chen, Q. et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392, 293–296, https://doi.org/10.1038/32675 (1998).

2. Brugada, P. & Brugada, J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20, 1391–1396 (1992).

3. Ruan, Y., Liu, N. & Priori, S. G. Sodium channel mutations and arrhythmias. Nat Rev Cardiol 6, 337–348, nrcardio.2009.44 (2009).

4. Antzelevitch, C. et al. Brugada syndrome: report of the second consensus conference. Heart Rhythm 2, 429–440, S1547-5271(05)00011-1 (2005).

5. Gaborit, N. et al. Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. J Physiol 582, 675–693, jphysiol.2006.126714 (2007).

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein-free media for cardiac differentiation of hPSCs in 2000 mL suspension culture;Stem Cell Research & Therapy;2024-07-18

2. Protein-free media for cardiac differentiation of hPSCs in 2000 mL suspension culture;2024-05-30

3. Application and perspective of CRISPR/Cas9 genome editing technology in human diseases modeling and gene therapy;Frontiers in Genetics;2024-04-11

4. In silico models of the macromolecular NaV1.5-KIR2.1 complex;Frontiers in Physiology;2024-02-26

5. The Potential of Human Induced Pluripotent Stem Cells (hiPSCs) for the Study of Channelopathies: Advances and Future Directions;Advances in Pluripotent Stem Cells;2024-01-31